Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA113339 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Fine needle aspiration biopsies (FNABs) of breast cancers were taken before and after surgeries from 16 patients. The cDNA microarray data were used to determine the gene expression profile responding to patient's clinical finding and tumor's pathological changes. A gene profile was generated as Estrogen Receptor Gene Signature (ERGS). The ERGS was verified in a reference dataset and correlated with patient's prognosis significantly. Keywords: Breast cancer, fine needle biopsy, estrogen receptor, prognostic gene signature
2009-07-01 | GSE12080 | GEO
Project description:Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
| PRJNA305002 | ENA
Project description:Fine needle aspiration biopsies (FNABs) of breast cancers were taken before and after surgeries from 16 patients. The cDNA microarray data were used to determine the gene expression profile responding to patient's clinical finding and tumor's pathological changes. A gene profile was generated as Estrogen Receptor Gene Signature (ERGS). The ERGS was verified in a reference dataset and correlated with patient's prognosis significantly. Keywords: Breast cancer, fine needle biopsy, estrogen receptor, prognostic gene signature Dye-swap technical replicates were included both FNABs taken before and after surgeries for every patient, then the four replicated array data per patient were combined for analysis.
2009-07-01 | E-GEOD-12080 | biostudies-arrayexpress
Project description:Estrogen-regulated genes predict survival in estrogen receptor and/or progesterone receptor-positive breast cancers
| PRJNA92235 | ENA
Project description:Prediction of Breast Cancer Estrogen Receptor Status using Machine Learning
| PRJNA140059 | ENA
Project description:MicroRNA signatures predict Estrogen receptor, Progesterone receptor and HER2/neu receptor status in Breast Cancer
| PRJNA117047 | ENA
Project description:Glucocorticoid receptor (GR) is a ligand-inducible transcription factor with an intricate role in cancer biology. Using an in silico designed GR activity signature we show that GR is a tumor suppressor across diverse primary cancers. In breast cancer, GR activity status determines luminal identity, and importantly, relates to patients’ outcomes. We illustrate that GR suppresses tumor growth, mediated through its engagement with the estrogen receptor-α (ER). This steroid hormone receptor cross-talk leads to redistribution of ERα on chromatin, ultimately leading to expression of ZBTB16 gene. We define ZBTB16 as a transcriptional repressor and a tumor suppressor in ER-positive breast cancer. Importantly, highly aggressive ER-positive breast cancer cells displaying absence of GR activity can be eradicated if GR-induced gene repression is mimicked by inhibitors of the epigenetic pathway. In line with this, epigenetic regulators are highly expressed upon GR activity loss, leading to vulnerability of aggressive breast cancer cells to clinically available epigenetic inhibitors. Our findings indicate that GR functions as a tumor suppressor by repositioning ER to specific sites on chromatin, modulating targetable pathways, which has important implications for patients’ prognosis and therapeutic interventions.
2023-10-02 | PXD039209 | Pride
Project description:Lipid metabolism genes in contralateral unaffected breast and estrogen receptor status of breast cancer
| PRJNA177679 | ENA
Project description:microRNA expression signature in estrogen receptor-positive and -negative breast cancers
| PRJNA495938 | ENA
Project description:Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
| PRJNA102769 | ENA